
Meshka Pharma LLP
About Meshka Pharma LLP
Data last updated:
Meshka Pharma LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 26 April 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAM-4964.
The LLP has a total obligation of contribution of ₹10 Lakh. It is led by designated partners including Mythili Srinivasan and Ayush Srinivasan.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹1.99 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹30.35 Lakh (net margin 15.3%) and EBITDA of ₹1.11 Cr (EBITDA margin 56%). Revenue has grown at a compounded annual rate (CAGR) of 75% over three years.
Meshka Pharma LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0047338).
Company details
Recognitions & Rankings of Meshka Pharma
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-27-0047338
Contact details
Meshka Pharma LLP's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address6/311 Sri Sai Industrial Chs Ltd Bldg. No. 6 Jogani Indl. Estate V N Purav Marg Chu, Nabhatti, Mumbai, Maharashtra, India – 400022
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Meshka Pharma LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Meshka Pharma LLP
FY 2025 filings availableMeshka Pharma LLP reported revenue of ₹1.99 Cr (down 12% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 75%. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹1.99 Cr | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹30.35 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 15.3% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Meshka Pharma LLP, buy the company report.
Designated partners of Meshka Pharma LLP
Meshka Pharma has 3 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mythili Srinivasan Also directs: Jinsei Naturals LLP | Designated Partner | 26 Apr 2018 | 8 Years 6 Months | Current |
| Ayush Srinivasan Also directs: Srikem Laboratories Private Limited | Designated Partner | 26 Apr 2018 | 8 Years 6 Months | Current |
| Srinivasan Subramaniam Also directs: Srikem Laboratories Private Limited | Designated Partner | 26 Apr 2018 | 8 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Meshka Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meshka Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Meshka Pharma LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Meshka Pharma LLP has 4 designated partner changes on record since 2018: 3 appointments and 1 cessation. The latest: Ramachandran Venkatrama Kuttucheri ceased to be Designated Partner on 27 Jul 2018.
Frequently asked questions
Meshka Pharma is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 26 April 2018 (8+ years old) and is registered under LLPIN AAM-4964.
Meshka Pharma has 3 current designated partners:
- Mythili Srinivasan - Designated Partner
- Ayush Srinivasan - Designated Partner
- Srinivasan Subramaniam - Designated Partner
The latest financial statements of Meshka Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2019 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Meshka Pharma is AAM-4964. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Meshka Pharma was incorporated on 26 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Ramachandran Venkatrama Kuttucheri ceased to be Designated Partner on 27 Jul 2018. Ayush Srinivasan was appointed as Designated Partner on 26 Apr 2018. Mythili Srinivasan was appointed as Designated Partner on 26 Apr 2018. Meshka Pharma has 4 designated partner changes on record in total.
Yes, Meshka Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Meshka Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0047338).
The registered office of Meshka Pharma is at 6311 Sri Sai Industrial Chs Ltd Bldg. No. 6 Jogani Indl. Estate V N Purav Marg Chu, Nabhatti, Mumbai, Maharashtra, India – 400022.
Meshka Pharma operates in the chemicals and materials industry, in the industrial chemicals segment.

